Translational research in infectious disease: current paradigms and challenges ahead.
In recent years, the biomedical community has witnessed a rapid scientific and technologic evolution after the development and refinement of high-throughput methodologies. Concurrently and consequentially, the scientific perspective has changed from the reductionist approach of meticulously analyzing the fine details of a single component of biology to the "holistic" approach of broadmindedly examining the globally interacting elements of biological systems. The emergence of this new way of thinking has brought about a scientific revolution in which genomics, proteomics, metabolomics, and other "omics" have become the predominant tools by which large amounts of data are amassed, analyzed, and applied to complex questions of biology that were previously unsolvable. This enormous transformation of basic science research and the ensuing plethora of promising data, especially in the realm of human health and disease, have unfortunately not been followed by a parallel increase in the clinical application of this information. On the contrary, the number of new potential drugs in development has been decreasing steadily, suggesting the existence of roadblocks that prevent the translation of promising research into medically relevant therapeutic or diagnostic application. In this article, we will review, in a noninclusive fashion, several recent scientific advancements in the field of translational research, with a specific focus on how they relate to infectious disease. We will also present a current picture of the limitations and challenges that exist for translational research, as well as ways that have been proposed by the National Institutes of Health to improve the state of this field.
Department of Public Health, Weill Cornell Medical College, New York, NY 10065, USA.
Judith M
JM
Fontana
Elizabeth
E
Alexander
Mirella
M
Salvatore
D003141:Communicable Diseases / Q000188:drug therapy / Q000209:etiology; D055808:Drug Discovery; D020022:Genetic Predisposition to Disease; D023281:Genomics; D057166:High-Throughput Screening Assays; D054884:Host-Pathogen Interactions; D006801:Humans; D055432:Metabolomics; D054892:Metagenome; D057285:Precision Medicine; D040901:Proteomics; D049490:Systems Biology; D057170:Translational Research, Biomedical; D014612:Vaccines / Q000494:pharmacology
D014612:Vaccines